Drug Shortage Report for ZESTORETIC
| Report ID | 244985 |
| Drug Identification Number | 02045737 |
| Brand name | ZESTORETIC |
| Common or Proper name | Zestoretic 20/12.5 |
| Company Name | SEARCHLIGHT PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE LISINOPRIL |
| Strength(s) | 12.5MG 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 30 tablets |
| ATC code | C09BA |
| ATC description | ACE INHIBITORS, COMBINATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-11-01 |
| Actual start date | 2024-11-01 |
| Estimated end date | 2025-03-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-12-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1600 RUE NOTRE DAME OUEST, SUITE 312 MONTREAL, QUEBEC CANADA H3J 1M1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-12-05 | French | Compare |
| v1 | 2024-12-05 | English | Compare |
Showing 1 to 2 of 2